Cardica Inc (CRDC) 0.95 $CRDC
Alere Q1 Earnings Rise, Revs Miss Ests - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu May 08, 12:10PM CDT
Since the earnings release, shares of Alere Inc. (ALR) rose 2.0% till yesterday.
Hanger Q1 Earnings and Revs Miss Ests, Shares Down - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed May 07, 1:10PM CDT
For 2014, Hanger Inc. (HGR) lowered its adjusted earnings per share guidance to a range of $2.01 to $2.11 from the prior range of $2.10 to $2.20.
Wright Medical Group Sees Broader Q1 Loss - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue May 06, 11:30AM CDT
For 2014, Wright Medical Group, Inc. (WMGI) anticipates adjusted loss per share in the range of $1.28 to $1.38.
What Makes Vascular Solutions (VASC) a Strong Sell? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri May 02, 7:54AM CDT
Vascular Solutions (VASC) has witnessed a significant price decline in the past four weeks, and it has seen negative earnings estimate revisions for the current quarter as well as the current year.
Cardiovascular Systems (CSII) Jumps: Stock Rises 8.4% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri May 02, 7:30AM CDT
Cardiovascular Systems (CSII) was a big mover last session, as its shares rose over 8% on the day.
Cardica Announces Fiscal 2014 Third Quarter Financial Results
PR Newswire - Thu May 01, 3:05PM CDT
Cardica, Inc. (Nasdaq: CRDC) today announced financial results for its fiscal third quarter ended March 31, 2014. Cardica's management will hold a conference call at 4:30 p.m. Eastern Time to discuss the financial results and provide an update on the company's business.
LeMaitre Vascular (LMAT) in Focus: Stock Rises 7.3% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu May 01, 8:46AM CDT
LeMaitre Vascular was a big mover last session, with shares rising over 7% on the day.
Cardica Announces Full Exercise of Overallotment Option
PR Newswire - Wed Apr 30, 7:00AM CDT
Cardica, Inc. (Nasdaq: CRDC) today announced the full exercise of the overallotment option granted to the underwriters to purchase an additional 4,875,000 shares of common stock at the public offering price, less the underwriter discount, in connection with the company's recently announced public offering of 32,500,000 shares of its common stock and 191,474 shares of its Series A convertible preferred stock. The lead investors in the completed offering were Broadfin Capital and Camber Capital Management. The closing for the additional purchase of 4,875,000 shares took place on April 29, 2014.
Cardica MicroCutter® XCHANGE 30 Named As Finalist In 2014 Medical Design Excellence Awards
PR Newswire - Mon Apr 28, 7:00AM CDT
Cardica, Inc. (Nasdaq: CRDC) today announced that its MicroCutter® XCHANGE 30 surgical stapler was selected as a finalist in the surgical Equipment, Instruments and Supplies category of the Medical Design Excellence Awards (MDEA), one of the highest honors in the medical technology industry. The MicroCutter XCHANGE 30 is the world's smallest articulating surgical stapler, with a five millimeter shaft diameter and reloadable cartridges. Winners of the awards will be announced on June 11 in New York.
Cardica MicroCutter® XCHANGE 30 Featured At Society Of American Gastrointestinal And Endoscopic Surgeons Meeting
PR Newswire - Thu Apr 24, 7:00AM CDT
Cardica, Inc. (Nasdaq: CRDC) today announced that Radu Pescarus, M.D., Foregut Fellow in the Gastrointestinal and Minimally Invasive Surgery Division of Providence Portland Medical Center, presented a poster detailing the pre-clinical use of the MicroCutter® XCHANGE 30 surgical stapling device in cutting-edge gastrointestinal surgical procedures including endoscopic assisted trans-gastric and trans-anal full thickness resections.
Cardica To Announce Fiscal 2014 Third Quarter Financial Results On Thursday, May 1, 2014
PR Newswire - Wed Apr 23, 7:00AM CDT
Cardica, Inc. (Nasdaq: CRDC) today announced that it will release financial results for its fiscal third quarter ended March 31, 2014, on Thursday, May 1, 2014, after the markets close. Cardica's management will host a conference call at 4:30 p.m. Eastern Time to discuss the financial results and provide an update on the company's business.
Hot Stock: Cardica, Shares Drop 6.4% (CRDC)
Comtex SmarTrend(R) - Wed Apr 16, 11:39AM CDT
Cardica (NASDAQ:CRDC) is one of today's worst performing penny stocks, down 6.4% to $0.88 on 5.8x average daily volume. Cardica has traded 1.3 million shares thus far today, vs. average volume of 218,000 shares per day. The stock has underperformed the Dow (-6.4% to the Dow's 0.8%) and underperformed the S&P 500 (-6.4% to the S&P's 0.8%) during today's trading.
Cardica Prices Public Offering of Common Stock and Preferred Stock
PR Newswire - Wed Apr 16, 7:00AM CDT
Cardica, Inc. (Nasdaq: CRDC) today announced the pricing of an underwritten public offering of 32,500,000 shares of its common stock, offered at a price to the public of $0.85 per share, and 191,474 shares of its Series A convertible preferred stock, offered at a price to the public of $85.00 per share. The Series A convertible preferred stock is non-voting and is convertible into shares of Cardica common stock at a conversion rate of 100 shares of common stock for each share of Series A convertible preferred stock, provided that conversion will be prohibited if, as a result, the holder and its affiliates would own more than 9.98% of the total number of shares of Cardica common stock then outstanding unless the holder gives Cardica at least 61 days prior notice of an intent to convert into shares of common stock that would cause the holder to own more than 9.98% of the total number of shares of common stock then issued and outstanding. Cardica has also granted to the underwriters an option to purchase up to an additional 4,875,000 shares of common stock to cover overallotments.
Cardica Announces Completion Of First U.S. Procedure Using MicroCutter XCHANGE(TM) 30 Stapling Device
PR Newswire - Tue Mar 11, 3:05PM CDT
Cardica, Inc. (Nasdaq: CRDC) today announced that Juan-Carlos Verdeja, M.D., F.A.C.S., completed the first surgical procedure in the United States using the MicroCutter XCHANGE(TM) 30 cutting and stapling device at West Kendall Baptist Hospital in Florida on March 3, 2014. The MicroCutter XCHANGE 30 is the only articulating five millimeter surgical stapler available today.
Cardica Receives 510(k) Clearance For Both MicroCutter XCHANGE(TM) 30 White Cartridge And New Material
PR Newswire - Thu Feb 27, 7:00AM CST
Cardica, Inc. (Nasdaq: CRDC) today announced it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its MicroCutter XCHANGE(TM) 30 white cartridge for the stapling of thin tissue for use in multiple open or minimally-invasive surgical procedures for the transection, resection and/or creation of anastomoses in small and large intestine, as well as the transection of the appendix. In addition, Cardica obtained 510(k) clearance for an additional plastic material contained within the MicroCutter XCHANGE 30 blue cartridge for use in medium thickness tissue. This material was submitted as a Special Premarket Notification 510(k) for the MicroCutter XCHANGE 30 device, which received FDA clearance in January 2014. With these clearances received Cardica does not have any other submissions pending at the FDA.
Cardica Announces Fiscal 2014 Second Quarter Financial Results
PR Newswire - Tue Feb 04, 3:05PM CST
Cardica, Inc. (Nasdaq: CRDC) today announced financial results for its fiscal second quarter ended December 31, 2013. Cardica's management will hold a conference call at 4:30 p.m. Eastern Time to discuss the financial results and provide an update on the company's business.
Cardica Inc. (CRDC) in Focus: Stock Moves 5.9% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Jan 29, 8:18AM CST
Cardica Inc. (CRDC) was a big mover last session, as the company saw its shares rise by almost 6% on the day.
Nonin Medical Announces United Kingdom and Ireland Distribution Agreement with Terumo Cardiovascular Group in Europe for Nonin's SenSmart(TM) Universal Oximetry System
PR Newswire - Tue Jan 28, 12:43PM CST
Nonin Medical, a leader in noninvasive medical monitoring, today announced that it has entered into a multi-year distribution agreement with Terumo Cardiovascular Group in Europe. As of January 2014, Terumo Cardiovascular Group will distribute Nonin's SenSmart(TM) Universal Oximetry System to all hospitals in the UK and Ireland. A similar distribution agreement between the two companies for the United States was announced in April 2013. Terumo manufactures and markets medical devices for the global cardiac surgery market.
Cardica To Announce Fiscal 2014 Second Quarter Financial Results On Tuesday, February 4, 2014
PR Newswire - Fri Jan 24, 7:00AM CST
Cardica, Inc. (Nasdaq: CRDC) today announced that it will release financial results for its fiscal second quarter ended December 31, 2013, on Tuesday, February 4, 2014, after the markets close. Cardica's management will host a conference call at 4:30 p.m. Eastern Time to discuss the financial results and provide an update on the company's business.
The Entrust Group Sees Increase in Self-Directed IRAs and Launches Ground-Breaking Technologies in 2013
PR Newswire - Wed Jan 22, 5:00AM CST
The Entrust Group, Inc., a pioneer and acknowledged authority in self-direction, today announced its top stories for fiscal year 2013 and set a new standard for the self-directed IRA industry. Amid various media reports of increased investor interest in self-direction, The Entrust Group saw 14.62 percent net growth in new accounts in 2013. In addition to this growth, The Entrust Group launched innovative tools that provide individuals the ability to educate themselves and conduct alternative investment transactions at their convenience, from anywhere in the world.
Alere Q1 Earnings Rise, Revs Miss Ests - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu May 08, 12:10PM CDT
Since the earnings release, shares of Alere Inc. (ALR) rose 2.0% till yesterday.
Hanger Q1 Earnings and Revs Miss Ests, Shares Down - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed May 07, 1:10PM CDT
For 2014, Hanger Inc. (HGR) lowered its adjusted earnings per share guidance to a range of $2.01 to $2.11 from the prior range of $2.10 to $2.20.
Wright Medical Group Sees Broader Q1 Loss - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue May 06, 11:30AM CDT
For 2014, Wright Medical Group, Inc. (WMGI) anticipates adjusted loss per share in the range of $1.28 to $1.38.
What Makes Vascular Solutions (VASC) a Strong Sell? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri May 02, 7:54AM CDT
Vascular Solutions (VASC) has witnessed a significant price decline in the past four weeks, and it has seen negative earnings estimate revisions for the current quarter as well as the current year.
Cardiovascular Systems (CSII) Jumps: Stock Rises 8.4% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri May 02, 7:30AM CDT
Cardiovascular Systems (CSII) was a big mover last session, as its shares rose over 8% on the day.
Cardica Announces Fiscal 2014 Third Quarter Financial Results
PR Newswire - Thu May 01, 3:05PM CDT
Cardica, Inc. (Nasdaq: CRDC) today announced financial results for its fiscal third quarter ended March 31, 2014. Cardica's management will hold a conference call at 4:30 p.m. Eastern Time to discuss the financial results and provide an update on the company's business.
LeMaitre Vascular (LMAT) in Focus: Stock Rises 7.3% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu May 01, 8:46AM CDT
LeMaitre Vascular was a big mover last session, with shares rising over 7% on the day.
Cardica Announces Full Exercise of Overallotment Option
PR Newswire - Wed Apr 30, 7:00AM CDT
Cardica, Inc. (Nasdaq: CRDC) today announced the full exercise of the overallotment option granted to the underwriters to purchase an additional 4,875,000 shares of common stock at the public offering price, less the underwriter discount, in connection with the company's recently announced public offering of 32,500,000 shares of its common stock and 191,474 shares of its Series A convertible preferred stock. The lead investors in the completed offering were Broadfin Capital and Camber Capital Management. The closing for the additional purchase of 4,875,000 shares took place on April 29, 2014.
Cardica MicroCutter® XCHANGE 30 Named As Finalist In 2014 Medical Design Excellence Awards
PR Newswire - Mon Apr 28, 7:00AM CDT
Cardica, Inc. (Nasdaq: CRDC) today announced that its MicroCutter® XCHANGE 30 surgical stapler was selected as a finalist in the surgical Equipment, Instruments and Supplies category of the Medical Design Excellence Awards (MDEA), one of the highest honors in the medical technology industry. The MicroCutter XCHANGE 30 is the world's smallest articulating surgical stapler, with a five millimeter shaft diameter and reloadable cartridges. Winners of the awards will be announced on June 11 in New York.
Cardica MicroCutter® XCHANGE 30 Featured At Society Of American Gastrointestinal And Endoscopic Surgeons Meeting
PR Newswire - Thu Apr 24, 7:00AM CDT
Cardica, Inc. (Nasdaq: CRDC) today announced that Radu Pescarus, M.D., Foregut Fellow in the Gastrointestinal and Minimally Invasive Surgery Division of Providence Portland Medical Center, presented a poster detailing the pre-clinical use of the MicroCutter® XCHANGE 30 surgical stapling device in cutting-edge gastrointestinal surgical procedures including endoscopic assisted trans-gastric and trans-anal full thickness resections.
Cardica To Announce Fiscal 2014 Third Quarter Financial Results On Thursday, May 1, 2014
PR Newswire - Wed Apr 23, 7:00AM CDT
Cardica, Inc. (Nasdaq: CRDC) today announced that it will release financial results for its fiscal third quarter ended March 31, 2014, on Thursday, May 1, 2014, after the markets close. Cardica's management will host a conference call at 4:30 p.m. Eastern Time to discuss the financial results and provide an update on the company's business.
Hot Stock: Cardica, Shares Drop 6.4% (CRDC)
Comtex SmarTrend(R) - Wed Apr 16, 11:39AM CDT
Cardica (NASDAQ:CRDC) is one of today's worst performing penny stocks, down 6.4% to $0.88 on 5.8x average daily volume. Cardica has traded 1.3 million shares thus far today, vs. average volume of 218,000 shares per day. The stock has underperformed the Dow (-6.4% to the Dow's 0.8%) and underperformed the S&P 500 (-6.4% to the S&P's 0.8%) during today's trading.
Cardica Prices Public Offering of Common Stock and Preferred Stock
PR Newswire - Wed Apr 16, 7:00AM CDT
Cardica, Inc. (Nasdaq: CRDC) today announced the pricing of an underwritten public offering of 32,500,000 shares of its common stock, offered at a price to the public of $0.85 per share, and 191,474 shares of its Series A convertible preferred stock, offered at a price to the public of $85.00 per share. The Series A convertible preferred stock is non-voting and is convertible into shares of Cardica common stock at a conversion rate of 100 shares of common stock for each share of Series A convertible preferred stock, provided that conversion will be prohibited if, as a result, the holder and its affiliates would own more than 9.98% of the total number of shares of Cardica common stock then outstanding unless the holder gives Cardica at least 61 days prior notice of an intent to convert into shares of common stock that would cause the holder to own more than 9.98% of the total number of shares of common stock then issued and outstanding. Cardica has also granted to the underwriters an option to purchase up to an additional 4,875,000 shares of common stock to cover overallotments.
Cardica Announces Completion Of First U.S. Procedure Using MicroCutter XCHANGE(TM) 30 Stapling Device
PR Newswire - Tue Mar 11, 3:05PM CDT
Cardica, Inc. (Nasdaq: CRDC) today announced that Juan-Carlos Verdeja, M.D., F.A.C.S., completed the first surgical procedure in the United States using the MicroCutter XCHANGE(TM) 30 cutting and stapling device at West Kendall Baptist Hospital in Florida on March 3, 2014. The MicroCutter XCHANGE 30 is the only articulating five millimeter surgical stapler available today.
Cardica Receives 510(k) Clearance For Both MicroCutter XCHANGE(TM) 30 White Cartridge And New Material
PR Newswire - Thu Feb 27, 7:00AM CST
Cardica, Inc. (Nasdaq: CRDC) today announced it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its MicroCutter XCHANGE(TM) 30 white cartridge for the stapling of thin tissue for use in multiple open or minimally-invasive surgical procedures for the transection, resection and/or creation of anastomoses in small and large intestine, as well as the transection of the appendix. In addition, Cardica obtained 510(k) clearance for an additional plastic material contained within the MicroCutter XCHANGE 30 blue cartridge for use in medium thickness tissue. This material was submitted as a Special Premarket Notification 510(k) for the MicroCutter XCHANGE 30 device, which received FDA clearance in January 2014. With these clearances received Cardica does not have any other submissions pending at the FDA.
Cardica Announces Fiscal 2014 Second Quarter Financial Results
PR Newswire - Tue Feb 04, 3:05PM CST
Cardica, Inc. (Nasdaq: CRDC) today announced financial results for its fiscal second quarter ended December 31, 2013. Cardica's management will hold a conference call at 4:30 p.m. Eastern Time to discuss the financial results and provide an update on the company's business.
Cardica Inc. (CRDC) in Focus: Stock Moves 5.9% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Jan 29, 8:18AM CST
Cardica Inc. (CRDC) was a big mover last session, as the company saw its shares rise by almost 6% on the day.
Nonin Medical Announces United Kingdom and Ireland Distribution Agreement with Terumo Cardiovascular Group in Europe for Nonin's SenSmart(TM) Universal Oximetry System
PR Newswire - Tue Jan 28, 12:43PM CST
Nonin Medical, a leader in noninvasive medical monitoring, today announced that it has entered into a multi-year distribution agreement with Terumo Cardiovascular Group in Europe. As of January 2014, Terumo Cardiovascular Group will distribute Nonin's SenSmart(TM) Universal Oximetry System to all hospitals in the UK and Ireland. A similar distribution agreement between the two companies for the United States was announced in April 2013. Terumo manufactures and markets medical devices for the global cardiac surgery market.
Cardica To Announce Fiscal 2014 Second Quarter Financial Results On Tuesday, February 4, 2014
PR Newswire - Fri Jan 24, 7:00AM CST
Cardica, Inc. (Nasdaq: CRDC) today announced that it will release financial results for its fiscal second quarter ended December 31, 2013, on Tuesday, February 4, 2014, after the markets close. Cardica's management will host a conference call at 4:30 p.m. Eastern Time to discuss the financial results and provide an update on the company's business.
The Entrust Group Sees Increase in Self-Directed IRAs and Launches Ground-Breaking Technologies in 2013
PR Newswire - Wed Jan 22, 5:00AM CST
The Entrust Group, Inc., a pioneer and acknowledged authority in self-direction, today announced its top stories for fiscal year 2013 and set a new standard for the self-directed IRA industry. Amid various media reports of increased investor interest in self-direction, The Entrust Group saw 14.62 percent net growth in new accounts in 2013. In addition to this growth, The Entrust Group launched innovative tools that provide individuals the ability to educate themselves and conduct alternative investment transactions at their convenience, from anywhere in the world.
